The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
A new strategy to fight antimicrobial resistance: the revival of old antibiotics
Open accessAbstract
The increasing prevalence of hospital and community-acquired infections caused by multidrug-resistant (MDR) bacterial pathogens is limiting the options for effective antibiotic therapy. Moreover, this alarming spread of antimicrobial resistance has not been paralleled by the development of novel antimicrobials. Resistance to the scarce new antibiotics is also emerging. In this context, the rational use of older antibiotics could represent an alternative to the treatment of MDR bacterial pathogens. It would help to optimize the armamentarium of antibiotics in the way to preserve new antibiotics and avoid the prescription of molecules known to favor the spread of resistance (i.e., quinolones). Furthermore, in a global economical perspective, this could represent a useful public health orientation knowing that several of these cheapest "forgotten" antibiotics are not available in many countries. We will review here the successful treatment of MDR bacterial infections with the use of old antibiotics and discuss their place in current practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726 · cited 2×
“It dramatically reduces the probability of effectively treating infections and increases the morbidity and mortality associated with common bacterial diseases (Klevens et al., 2007).”
BackgroundInfluentialGupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq257 · Cited by 3,038
Stevens, D. L., Bisno, A. L., Chambers, H. F., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu296 · Cited by 2,780
Antibiotic resistance is ancient
D’Costa, V. M., King, C. E., Kalan, L., Morar, M., Sung, W. W. L., Schwarz, C., Froese, D., Zazula, G., Calmels, F., Debruyne, R., et al. (2011) · Nature · doi:10.1038/nature10388 · Cited by 2,720
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
Moran, G. J., Krishnadasan, A., Gorwitz, R. J., Fosheim, G. E., McDougal, L. K., Carey, R. B., & Talan, D. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055356 · Cited by 2,285
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Li, J., Nation, R. L., Turnidge, J. D., Milne, R. W., Coulthard, K., Rayner, C. R., & Paterson, D. L. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70580-1 · Cited by 1,388
Seppälä, H., Klaukka, T., Vuopio-Varkila, J., Muotiala, A., Helenius, H., Lager, K., & Huovinen, P. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370701 · Cited by 1,206
Trends in antimicrobial drug development: Implications for the future
Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/420937 · Cited by 867
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Effect of antimicrobial agents on the ecological balance of human microflora
Sullivan, Å., Edlund, C., & Nord, C. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00066-4 · Cited by 818
Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis
Van Deun, A., Maug, A. K. J., Salim, M. A. H., Das, P. K., Sarker, M. R., Daru, P., & Rieder, H. L. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0077oc · Cited by 647
Colistin: an update on the antibiotic of the 21st century
Biswas, S., Brunel, J.-M., Dubus, J.-C., Reynaud-Gaubert, M., & Rolain, J.-M. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.78 · Cited by 581
Self-citationBest drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Caminero, J. A., Sotgiu, G., Zumla, A., & Migliori, G. B. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70139-0 · Cited by 574
Cai, Y., Chai, D., Wang, R., Liang, B., & Bai, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks084 · Cited by 557
Garnacho‐Montero, J., Ortiz‐Leyba, C., Jimenez‐Jimenez, F. J., Barrero‐Almodovar, A. E., Garcia‐Garmendia, J. L., Bernabeu‐WittelI, M., Gallego‐Lara, S. L., & Madrazo‐Osuna, J. (2003) · Clinical Infectious Diseases · doi:10.1086/374337 · Cited by 470
The history of the tetracyclines
Nelson, M. L., & Levy, S. B. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06354.x · Cited by 468
Comprehensive Treatment of Extensively Drug-Resistant Tuberculosis
Mitnick, C. D., Shin, S. S., Seung, K. J., Rich, M. L., Atwood, S. S., Furin, J. J., Fitzmaurice, G. M., Alcantara Viru, F. A., Appleton, S. C., Bayona, J. N., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800106 · Cited by 402
Roberts, M. C. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01145.x · Cited by 392
Diep, B. A., Chambers, H. F., Graber, C. J., Szumowski, J. D., Miller, L. G., Han, L. L., Chen, J. H., Lin, F., Lin, J., Phan, T. H., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00204 · Cited by 391
Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome
Long, K. S., & Vester, B. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05702-11 · Cited by 375
Looming Global-Scale Failures and Missing Institutions
Walker, B., Barrett, S., Polasky, S., Galaz, V., Folke, C., Engström, G., Ackerman, F., Arrow, K., Carpenter, S., Chopra, K., et al. (2009) · Science · doi:10.1126/science.1175325 · Cited by 365
Deshpande, L. M., Fritsche, T. R., Moet, G. J., Biedenbach, D. J., & Jones, R. N. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.12.022 · Cited by 345
Markowitz, N., Quinn, E. L., & Saravolatz, L. D. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-390 · Cited by 343
Siberry, G. K., Tekle, T., Carroll, K., & Dick, J. (2003) · Clinical Infectious Diseases · doi:10.1086/377501 · Cited by 343
Livermore, D. M., Warner, M., Mushtaq, S., Doumith, M., Zhang, J., & Woodford, N. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.01.012 · Cited by 341
MARTÍNEZ-AGUILAR, G., HAMMERMAN, W. A., MASON, E. O., & KAPLAN, S. L. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000073163.37519.ee · Cited by 315
Markou, N., Apostolakos, H., Koumoudiou, C., Athanasiou, M., Koutsoukou, A., Alamanos, I., & Gregorakos, L. (2003) · Critical Care · doi:10.1186/cc2358 · Cited by 278
Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus
Trzcinski, K., Cooper, B. S., Hryniewicz, W., & Dowson, C. G. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.6.763 · Cited by 275
Linden, P. K., Kusne, S., Coley, K., Fontes, P., Kramer, D. J., & Paterson, D. (2003) · Clinical Infectious Diseases · doi:10.1086/379611 · Cited by 252
Wachi, M., Doi, M., Tamaki, S., Park, W., Nakajima-Iijima, S., & Matsuhashi, M. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.11.4935-4940.1987 · Cited by 242
Rifampin Combination Therapy for Nonmycobacterial Infections
Forrest, G. N., & Tamura, K. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-09 · Cited by 242
Mohamed, A. F., Karaiskos, I., Plachouras, D., Karvanen, M., Pontikis, K., Jansson, B., Papadomichelakis, E., Antoniadou, A., Giamarellou, H., Armaganidis, A., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06426-11 · Cited by 234
Betrosian, A. P., Frantzeskaki, F., Xanthaki, A., & Douzinas, E. E. (2008) · Journal of Infection · doi:10.1016/j.jinf.2008.04.002 · Cited by 230
Pontikis, K., Karaiskos, I., Bastani, S., Dimopoulos, G., Kalogirou, M., Katsiari, M., Oikonomou, A., Poulakou, G., Roilides, E., & Giamarellou, H. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.09.010 · Cited by 220
Ruhe, J. J., Smith, N., Bradsher, R. W., & Menon, A. (2007) · Clinical Infectious Diseases · doi:10.1086/511872 · Cited by 214
Lu, Q., Luo, R., Bodin, L., Yang, J., Zahr, N., Aubry, A., Golmard, J.-L., & Rouby, J.-J. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31827515de · Cited by 207
Kofteridis, D. P., Alexopoulou, C., Valachis, A., Maraki, S., Dimopoulou, D., Georgopoulos, D., & Samonis, G. (2010) · Clinical Infectious Diseases · doi:10.1086/657242 · Cited by 207
Mouton, J. W., Ambrose, P. G., Canton, R., Drusano, G. L., Harbarth, S., MacGowan, A., Theuretzbacher, U., & Turnidge, J. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.02.005 · Cited by 200
Frye, J. G., & Jackson, C. R. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00135 · Cited by 196
Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli
Sandegren, L., Lindqvist, A., Kahlmeter, G., & Andersson, D. I. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn222 · Cited by 196
Neuner, E. A., Sekeres, J., Hall, G. S., & van Duin, D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00402-12 · Cited by 189
Tumbarello, M., De Pascale, G., Trecarichi, E. M., De Martino, S., Bello, G., Maviglia, R., Spanu, T., & Antonelli, M. (2013) · Chest · doi:10.1378/chest.13-1018 · Cited by 182
Howden, B. P., & Grayson, M. L. (2006) · Clinical Infectious Diseases · doi:10.1086/499365 · Cited by 182
Hidron, A. I., Low, C. E., Honig, E. G., & Blumberg, H. M. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70133-1 · Cited by 180
Ruhe, J. J., Monson, T., Bradsher, R. W., & Menon, A. (2005) · Clinical Infectious Diseases · doi:10.1086/429628 · Cited by 166
Motaouakkil, S., Charra, B., Hachimi, A., Nejmi, H., Benslama, A., Elmdaghri, N., Belabbes, H., & Benbachir, M. (2006) · Journal of Infection · doi:10.1016/j.jinf.2005.11.019 · Cited by 165
Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
Bassetti, M., Repetto, E., Righi, E., Boni, S., Diverio, M., Molinari, M. P., Mussap, M., Artioli, S., Ansaldi, F., Durando, P., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm509 · Cited by 163
Dubourg, G., Lagier, J., Armougom, F., Robert, C., Hamad, I., Brouqui, P., & Raoult, D. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1787-3 · Cited by 162
Self-citationGodtfredsen, W. O., Roholt, K., & Tybring, L. (1962) · The Lancet · doi:10.1016/s0140-6736(62)91968-2 · Cited by 156
Kallel, H., Hergafi, L., Bahloul, M., Hakim, A., Dammak, H., Chelly, H., Hamida, C. B., Chaari, A., Rekik, N., & Bouaziz, M. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0675-2 · Cited by 154
Diene, S. M., Merhej, V., Henry, M., Filali, A. E., Roux, V., Robert, C., Azza, S., Gavory, F., Barbe, V., Scola, B. L., et al. (2012) · Molecular Biology and Evolution · doi:10.1093/molbev/mss236 · Cited by 151
Self-citationStein, A., Bataille, J. F., Drancourt, M., Curvale, G., Argenson, J., Groulier, P., & Raoult, D. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3086 · Cited by 150
McGehee, R. F., Smith, C. B., Wilcox, C., & Finland, M. (1968) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196811000-00002 · Cited by 148
Lee, S.-Y., Park, Y. J., Yu, J. K., Jung, S., Kim, Y., Jeong, S. H., & Arakawa, Y. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks319 · Cited by 148
Me, J.-M., Pichardo-Guerrero, C., Márquez-Rivas, J., Martín-Lozano, D., Prados, T., & Pachón, J. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-001-0680-2 · Cited by 145
Trends in antimicrobial drug development: Implications for the future
Sergio Mella, M. (2005) · Revista chilena de infectología · doi:10.4067/s0716-10182005000200011 · Cited by 143
Role of Folate Antagonists in the Treatment of Methicillin-Resistant Staphylococcus aureus Infection
Goldstein, E. J. C., & Proctor, R. A. (2008) · Clinical Infectious Diseases · doi:10.1086/525536 · Cited by 138
Slocombe, B., BASKER, M. J., Bentley, P. H., Clayton, J., Cole, M., Comber, K. R., DIXON, R. A., Edmondson, R. A., Jackson, D., Merrikin, D. J., et al. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.20.1.38 · Cited by 135
Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
Francisco, C. N.-S., Mora-Rillo, M., Romero‐Gómez, M. P., Moreno-Ramos, F., Rico-Nieto, A., Carrascoso, G. R., Gómez-Gil, R., Arribas, J. R., Mingorance, J., & Paño‐Pardo, J. R. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12091 · Cited by 130
Livermore, D. M., & Tulkens, P. M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn511 · Cited by 129
Ruhe, J., & Menon, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00262-07 · Cited by 122
Koomanachai, P., Tiengrim, S., Kiratisin, P., & Thamlikitkul, V. (2007) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2006.09.011 · Cited by 119
Amoxicillin-Clavulanic Acid for Treating Drug-Resistant Mycobacterium tuberculosis
Nadler, J. P., Berger, J., Nord, J. A., Cofsky, R., & Saxena, M. (1991) · CHEST Journal · doi:10.1378/chest.99.4.1025 · Cited by 112
Balakrishnan, I., Awad-El-Kariem, F. M., Aali, A., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr317 · Cited by 111
Castanheira, M., Watters, A. A., Mendes, R. E., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq094 · Cited by 111
Forgotten Antibiotics: An Inventory in Europe, the United States, Canada, and Australia
Pulcini, C., Bush, K., Craig, W. A., Møller, J. K., Grayson, M. L., Mouton, J. W., Turnidge, J. D., Harbarth, S., Gyssens, I. C., & the ESCMID Study Group for Antibiotic Policies (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir838 · Cited by 105
Tuberculosis and Trimethoprim-Sulfamethoxazole
Forgacs, P., Wengenack, N. L., Hall, L. S., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01658-08 · Cited by 105
Rolain, J., Diene, S. M., Kempf, M., Gimenez, G., Robert, C., & Raoult, D. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01314-12 · Cited by 104
Self-citationCenizal, M. J., Skiest, D. J., Luber, S., Bedimo, R., Davis, P., Fox, P., Delaney, K., & Hardy, R. D. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00206-07 · Cited by 103
Lautenbach, E., Schuster, M. G., Bilker, W. B., & Brennan, P. J. (1998) · Clinical Infectious Diseases · doi:10.1086/515002 · Cited by 100
Shean, K., Streicher, E. M., Pieterson, E., Symons, G., van Zyl-Smit, R. N., Theron, G., Lehloenya, R. J., Padanilam, X., Wilcox, P. D., Victor, T. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063057 · Cited by 99
Vancomycin‐Resistant Enterococcal Urinary Tract Infections
Heintz, B. H., Halilovic, J., & Christensen, C. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.11.1136 · Cited by 99
Grim, S. A., Rapp, R. P., Martin, C. A., & Evans, M. E. (2005) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.25.2.253.56956 · Cited by 96
Falagas, M. E., Kasiakou, S. K., Kofteridis, D. P., Roditakis, G., & Samonis, G. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0191-2 · Cited by 95
Jongh, R. F. D., Hens, R., Basma, V., Mouton, J. W., Tulkens, P. M., & Carryn, S. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm467 · Cited by 93
Søraas, A. V. L., Sundsfjord, A., Jørgensen, S. B., Liestøl, K., & Jenum, P. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085889 · Cited by 83
Ventilator-associated pneumonia due to colistin susceptible-only microorganisms
Ríos, F. G., Luna, C. M., Maskin, B. C., Valiente, A., Lloria, M., Gando, S., Sosa, C., Baquero, S., Llerena, C., Petrati, C., et al. (2007) · European Respiratory Journal · doi:10.1183/09031936.00156906 · Cited by 83
Williamson, D. A., Monecke, S., Heffernan, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu658 · Cited by 80
Livermore, D. M., Hope, R., Fagan, E. J., Warner, M., Woodford, N., & Potz, N. A. C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl043 · Cited by 79
Senol, S., Tasbakan, M. I., Pullukçu, H., Sipahi, O. R., Sipahi, H., Yamazhan, T., Arda, B., & Ulusoy, S. (2010) · Journal of Chemotherapy · doi:10.1179/joc.2010.22.5.355 · Cited by 78
Antimicrobial resistance in commensal Escherichia coli isolated from animals at slaughter
Wasyl, D., Hoszowski, A., Zając, M., & Szulowski, K. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00221 · Cited by 78
Old antibiotics for infections in critically ill patients
Falagas, M. E., & Kopterides, P. (2007) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32827851d7 · Cited by 77
Trimethoprim/Sulfamethoxazole for Treatment of Severe Staphylococcus aureus Infections
Adra, M., & Lawrence, K. R. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d156 · Cited by 77
Dewar, S., Reed, L. C., & Koerner, R. J. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt368 · Cited by 72
Pivmecillinam?therapy of choice for lower urinary tract infection
Graninger, W. B. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00235-8 · Cited by 70
Ferry, T., Uçkay, İ., Vaudaux, P. E., François, P., Schrenzel, J., Harbarth, S., Laurent, F. J., Bernard, L., Vandenesch, F., Étienne, J., et al. (2009) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-009-0837-y · Cited by 70
Jansåker, F., Frimodt‐Møller, N., Sjogren, I., & Knudsen, J. D. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt404 · Cited by 66
Tasbakan, M. I., Pullukçu, H., Sipahi, O. R., Yamazhan, T., & Ulusoy, S. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.08.003 · Cited by 65
Chen, A. E., Goldstein, M. A., Carroll, K. C., Song, X., Perl, T. M., & Siberry, G. K. (2006) · Pediatric Emergency Care · doi:10.1097/01.pec.0000236832.23947.a0 · Cited by 63
Nakaya, H., Yasuhara, A., Yoshimura, K., Oshihoi, Y., Izumiya, H., & Watanabe, H. (2003) · Emerging infectious diseases · doi:10.3201/eid0902.020185 · Cited by 63
In vitro activity of temocillin against extended spectrum β-lactamase-producing Escherichia coli
Rodriguez‐Villalobos, H., Malaviolle, V., Frankard, J., Mendonça, R. D., Nonhoff, C., & Struelens, M. J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl046 · Cited by 63
Karageorgopoulos, D. E., Miriagou, V., TZOUVELEKIS, L. S., Spyridopoulou, K., & Daikos, G. L. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks270 · Cited by 60
Linezolid resistance in Enterococcus faecium isolated in Ontario, Canada
PATEL, S. N., Memari, N., Shahinas, D., Toye, B. W., Jamieson, F., & Farrell, D. J. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.08.012 · Cited by 59
Trimethoprim-sulfamethoxazole Therapy for Children With Acute Osteomyelitis
Messina, A. F., Namtu, K. C., Guild, M., Dumois, J. A., & Berman, D. M. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31822db658 · Cited by 55
Goldberg, E., Paul, M., Talker, O., Samra, Z., Raskin, M., Hazzan, R., Leibovici, L., & Bishara, J. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq179 · Cited by 55
Oostdijk, E. A. N., Smits, L. P., de Smet, A. M. G. A., Hall, M. A. L., Kesecioğlu, J., & Bonten, M. J. M. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2761-3 · Cited by 53
Schwartz, B. S., Graber, C. J., Diep, B. A., Basuino, L., Perdreau‐Remington, F., & Chambers, H. F. “. (2009) · Clinical Infectious Diseases · doi:10.1086/598510 · Cited by 51
Górgolas, M., Avilés, P., Verdejo, C., & Guerrero, M. L. F. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.953 · Cited by 50
Revisiting “Older” Antimicrobials in the Era of Multidrug Resistance
Pogue, J. M., Marchaim, D., Kaye, D., & Kaye, K. S. (2011) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.31.9.912 · Cited by 48
Treatment of severe staphylococcal infections with a rifampicin-minocycline association
Clumeck, N., Marcelis, L., Mh, A.-L., & Gordts, B. (1984) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/13.suppl_c.17 · Cited by 45
Campbell, M. L., Marchaim, D., Pogue, J. M., Sunkara, B., Bheemreddy, S., Bathina, P., Pulluru, H., Chugh, N., Wilson, M. N., Moshos, J. A., et al. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1r211 · Cited by 45
Pseudomonas aeruginosa Susceptible Only to Colistin in Intensive Care Unit Patients
Mastoraki, A. T., Douka, E., Kriaras, I., Stravopodis, G., Manoli, H., & Geroulanos, S. (2008) · Surgical Infections · doi:10.1089/sur.2007.004 · Cited by 43
Titelman, E., Iversen, A., Kalin, M., & Giske, C. G. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0161 · Cited by 41
Antibacterial resistance and their genetic location in MRSA isolated in Kuwait hospitals, 1994-2004
Udo, E. E., Al‐Sweih, N., Mokaddas, E. M., Johny, M., Dhar, R., Gomaa, H. H. A., Al‐Obaid, I., & Rotimi, V. O. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-168 · Cited by 39
Cadena, J., Nair, S., Henao‐Martínez, A. F., Jorgensen, J. H., PATTERSON, J. E., & Sreeramoju, P. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00706-11 · Cited by 39
Katopodis, G. D., Grivea, I. N., Tsantsaridou, A., Pournaras, S., Petinaki, E., & Syrogiannopoulos, G. A. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-351 · Cited by 39
Amikacin and colistin for treatment of Acinetobacter baumannii meningitis
Fulnecky, E. J., Wright, D., Scheld, W. M., Kanawati, L., & Shoham, S. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.04.003 · Cited by 39
Lawlor, M.-K., Sullivan, M. C., Levitz, R. E., Quintiliani, R., & Nightingale, C. H. (1990) · The Journal of Infectious Diseases · doi:10.1093/infdis/161.4.812 · Cited by 38
Pristinamycin: old drug, new tricks?
Cooper, E. C., Curtis, N. C., Cranswick, N., et al. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku167 · Cited by 35
Changchien, C., Chen, Y., Chen, S.-W., Chen, W.-L., Tsay, J.-G., & Chu, C. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-297 · Cited by 32
Murray, R. J., Pearson, J. C., Coombs, G. W., Flexman, J., Golledge, C. L., Speers, D. J., Dyer, J. R., McLellan, D. G., Reilly, M., Bell, J. M., et al. (2008) · Infection Control and Hospital Epidemiology · doi:10.1086/590260 · Cited by 32
Bosman, A. B., Wagenaar, J. A., Stegeman, A., Vernooij, J. C. M., & Mevius, D. J. (2013) · Epidemiology and Infection · doi:10.1017/s0950268813002665 · Cited by 31
van der Veen, E. L., Schilder, A. G., Timmers, T. K., Rovers, M. M., Fluit, A. C., Bonten, M. J. M., & Hall, M. A. L. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp050 · Cited by 31
Tamer, M. A., & Bray, J. D. (1982) · Clinical Pediatrics · doi:10.1177/000992288202100211 · Cited by 30
Wood, J. B., Smith, D. B., Baker, E. H., Brecher, S. M., & Gupta, K. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01011-12 · Cited by 26
Trimethoprim-Sulfamethoxazole in The Treatment of Bacterial Endocarditis
Seligman, S. J., Madhavan, T., & Alcid, D. V. (1973) · The Journal of Infectious Diseases · doi:10.1093/infdis/128.supplement_3.s754 · Cited by 26
Trimethoprim-Sulphamethoxazole Treatment in Staphylococcal Endocarditis and Gram-Negative Septicemia
Bengtsson, E., Svanbom, M., & Tunevall, G. (1974) · Scandinavian Journal of Infectious Diseases · doi:10.3109/inf.1974.6.issue-2.13 · Cited by 24
Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections
Pea, F., & Viale, P. (2007) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.5.2.255 · Cited by 20
Cunha, B. A. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.08.006 · Cited by 19
Inhaled antibiotics in mechanically ventilated patients.
Michalopoulos, A. S., & Falagas, M. E. (2014) · PubMed · Cited by 18
Carlo, P. D., D’Alessandro, N., Guadagnino, G., Bonura, C., Mammina, C., Lunetta, M., Novo, S., & Giarratano, A. (2013) · PubMed · Cited by 18
Kefala, K., Protonotariou, E., Vitti, D., Sarafidou, S., Anastasiou, A. L., Kollios, K. D., & Roilides, E. (2009) · European Journal of Pediatrics · doi:10.1007/s00431-009-0977-1 · Cited by 18
Shafqat, S. H., Shah, S. A., & Seyed, S. A. (1971) · Heart · doi:10.1136/hrt.33.6.974 · Cited by 13
Serum concentration of co-trimoxazole during a high-dosage regimen
Ameen, S. M., Rolain, J., Poullain, M.-N. L., et al. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt400 · Cited by 13
Self-citationRue, M., Usandizaga, F. C., Fontecha, C. G., Bartolomé-Comas, R., & Llop, F. A. M. (2009) · Anales de Pediatría · doi:10.1016/j.anpedi.2008.11.027 · Cited by 11
Cited by
Rajeshkumar, S., & Bharath, L. V. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.06.019 · Cited by 465
Rescuing the Last-Line Polymyxins: Achievements and Challenges
Nang, S. C., Azad, M. A. K., Velkov, T., Zhou, Q. (., & Li, J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000020 · Cited by 421
Karampatakis, T., Tsergouli, K., & Behzadi, P. (2023) · Antibiotics · doi:10.3390/antibiotics12020234 · Cited by 339
Colistin Update on Its Mechanism of Action and Resistance, Present and Future Challenges
Andrade, F. F., Silva, D., Rodrigues, A., & Pina-Vaz, C. (2020) · Microorganisms · doi:10.3390/microorganisms8111716 · Cited by 284
Yousefi, M., Dadashpour, M., Hejazi, M., Hasanzadeh, M., Behnam, B., de la Guardia, M., Shadjou, N., & Mokhtarzadeh, A. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.12.125 · Cited by 258
Metadata
- Authors
- Cassir, N., Rolain, J.-M., & Brouqui, P.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2014-10-20
- Volume
- 5
- Pages
- 551-551
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2076639843
- Cited by
- 280
- References
- 129
- FWCI
- 17.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.